SOPHiA GENETICS to Participate in Fireside Chat at Barclays Global Healthcare Conference
March 04 2022 - 8:00AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven
medicine, announced today Chief Executive Officer and Co-Founder
Dr. Jurgi Camblong will participate in a fireside chat at the
Barclays Global Healthcare Conference on Wednesday, March 16 at
11:15 a.m. ET/5:15 p.m. CET at the Loews Miami Beach Hotel in
Miami, FL, United States.
A live webcast and replay of the session will be available on
the investor relations section of the SOPHiA GENETICS website at
https://ir.sophiagenetics.com.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology
company dedicated to establishing the practice of data-driven
medicine as the standard of care and for life sciences research. It
is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS
platform capable of analyzing data and generating insights from
complex multimodal data sets and different diagnostic modalities.
The SOPHiA DDM™ Platform and related solutions, products and
services are currently used by more than 790 hospital, laboratory,
and biopharma institutions globally. For more information, visit
SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn and Instagram.
Where others see data, we see answers.
Investor Contact:Jennifer PottageHead of
Investor RelationsJpottage@sophiagenetics.com
Media Contact:Eliza BamontiDirector of Public
RelationsEbamonti@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024